| Document |
Document Title |
|
WO/2019/068458A1 |
The present invention provides a composition comprising a) a phase change material; b) 1 to 10 wt% of a silica gelling additive; and c) a styrene co-polymer gelling additive; wherein the composition is in the form of a gel and wherein th...
|
|
WO/2019/064290A1 |
A composition, comprising a hydrogel matrix and microparticles within said matrix, said matrix comprising a cross-linkable protein and a cross-linking agent, wherein said cross-linking agent is able to cross-link said cross-linkable prot...
|
|
WO/2019/063997A1 |
A wound treatment composition comprises honey and a gelling agent dispersed in water, and forms a gel on contact with wound exudate. The composition may be prepared by dispersing the gelling agent in water and mixing the water and gellin...
|
|
WO/2019/058375A1 |
The present disclosure provides a wound dressing assembly comprising (i) a blood-clotting mold device having an enclosure defined between walls of a main body and a removable closure over an opening and is configured for introduction of ...
|
|
WO/2019/052171A1 |
The purpose of the present invention is to provide a light control agent and explore its application, and is expected to improve the tissue binding force and convenience of the existing biological glue material by providing a new reagent...
|
|
WO/2019/050479A1 |
According to the present disclosure, a bioadhesive formulation is provided. The bioadhesive formulation comprises a polycaprolactone dendrimer having a dendrimer core and a plurality of polycaprolactone chains extending from the dendrime...
|
|
WO/2019/045360A2 |
The present invention relates to a keloid prevention or treatment method using a liquid phase plasma. A liquid phase plasma according to the present invention has a significant effect of inhibiting the formation and proliferation of kelo...
|
|
WO/2019/040729A1 |
A biomaterial that includes collagen and an antimicrobial agent such as citric acid is provided herein. The biomaterial may further include a metal, such as silver, and an anionic polysaccharide, such as oxidized regenerated cellulose (O...
|
|
WO/2019/040425A1 |
Disclosed methods include formulating azobenzene-based polymer networks to induce a modulus change in a highly crosslinked polymer, in vivo, with no external heat requirement and using a benign light as the source of stimuli. A modulus c...
|
|
WO/2019/035928A1 |
Disclosed are a peptide capable of induced self-assembly by a bioactive molecule comprising a (i) hydrogelation-promoting amino acid sequence and (ii) an oligomerization sequence; compositions containing the peptide and, optionally, bioa...
|
|
WO/2019/016705A1 |
The present patent application describes a film developed from components of natural origin for covering wounds, the method of application of said film being in the form of individual disposable packaging, ampules, syringes and/or other ...
|
|
WO/2019/012226A1 |
An interface dressing (1) comprising an elastomeric matrix (5), the elastomeric matrix (5) being provided with a plurality of through-holes (6), each through-hole (6) having a contour (C) around a central axis (A), in which at least some...
|
|
WO/2019/008331A1 |
A method for manufacturing alcoholic liquid compositions, the method comprises the steps of: · providing an alcoholic liquid composition; • contacting unhydrated hydrocolloid with the alcoholic liquid composition to provide a hydrocol...
|
|
WO/2018/226383A1 |
In an embodiment, a pH-responsive drug delivery composition for prolonged drug delivery to a mucosal surface is provided. At acidic pH, the matrix self-seal and forms entity that protects the peptide/drug inside. Upon contact with fluids...
|
|
WO/2018/213433A1 |
Medical adhesives formed from macromers having a polymeric backbone, pendant chains bearing crosslinkable groups, and pendant groups with primary amine end groups. When crosslinked, the macromers form hydrogels having many properties adv...
|
|
WO/2018/200695A1 |
The present invention relates to a long-lasting medical product for protecting or treating a lesion in the gastrointestinal tract. The medical product includes a protective covering, wherein the medical product upon application at and ab...
|
|
WO/2018/200574A1 |
Disclosed are a mixture of modified polysaccharides and the process of making the modified polysaccharides. Embodiments disclose processing and applying a preparation of the mixture of modified polysaccharides in combination with other b...
|
|
WO/2018/200372A1 |
Disclosed herein is a hydrogel wound dressing having a wound-contact side and a non-wound-contact side wherein the rate of moisture evaporation from said non-wound contact side is faster than the rate of moisture evaporation from said wo...
|
|
WO/2018/194132A1 |
The present invention pertains to a method for forming a coating film, said coating film containing fibers and having excellent adhesiveness to the skin, through electrostatic spray directly to the skin. A method for forming a fiber-cont...
|
|
WO/2018/191800A1 |
Device for applying fibrin biopolymers, such biopolymers being formed of two or more components which must necessarily be mixed only at the time of use, said device (1) being formed of an adhesive bandage (2), the lower adhesive area of ...
|
|
WO/2018/190613A1 |
The present invention relates to a powder composition for wound healing comprising S-nitrosoglutathione (GSNO), alginate salt, pectin and polyethylene glycol (PEG) as active ingredients, and a method for producing the same. As the compos...
|
|
WO/2018/191409A1 |
This disclosure provides generally for antimicrobial compositions and methods of use comprising an anthocyanin, an anthocyanidin or metabolites thereof. Methods for promoting healing of a wound using these compositions are also disclosed...
|
|
WO/2018/186658A1 |
The present invention relates to a kit for treating or relieving the pain at an incision site. According to the present invention, provided is a kit for treating or relieving the pain at an incision site following a surgical procedure, w...
|
|
WO/2018/178597A1 |
The present invention relates to a film-forming liquid composition comprising at least one film-forming polymer derived from cellulose, at least one plasticiser and at least one volatile solvent. The invention also relates to a method fo...
|
|
WO/2018/184021A1 |
The present invention relates, in part, to hydrophobically-modified polymers and foams and their use in the control of bleeding.
|
|
WO/2018/150307A1 |
The present disclosure generally relates to a dispenser and/or applicator. In some embodiments, the dispenser and/or applicator includes a nozzle and a cap. In some embodiments, the dispenser and/or applicator is used to dispense a banda...
|
|
WO/2018/148455A1 |
A new method of targeted intrasite drug administration to wounds offers advantages in treatment efficacy and safety over traditional routes of administration. A novel method of dosing intrasite medications based on wound surface area pro...
|
|
WO/2018/147986A1 |
Disclosed are compositions that comprise an organic electrochemical mediator and a gasotransmitter salt which converts into a gasotransmitter via electron transfer. Also disclosed are bandages and wound dressings comprising the subject g...
|
|
WO/2018/124572A1 |
The present invention relates to a silicon resin composition, a preparation method therefor, and a scar treatment agent including the same and, more specifically, to a silicon resin composition, a preparation method therefor, and a scar ...
|
|
WO/2018/121706A1 |
Curable organopolysiloxane compositions and their cured products with superior properties is described as well as their uses as materials for optical devices, such as LEDs.
|
|
WO/2018/115257A1 |
The invention relates to water-containing hydrogels for dressing wounds, comprising a polyurethane-polyurea copolymer having a polyvalent alcohol, except propylene glycol.
|
|
WO/2018/115453A1 |
The invention relates to a water-containing hydrogel composition, comprising elemental silver particles, and a multi-layer wound dressing comprising the hydrogel composition. The multi-layer wound dressing is used in particular in the in...
|
|
WO/2018/116287A1 |
Provided are compositions comprising an anion exchanger and a calcium salt for use as a medicament for inducing hemostasis at a site of bleeding; and methods of preparation thereof.
|
|
WO/2018/109051A1 |
The invention relates to a composition for dressing cutaneous lesions, in particular cutaneous leishmanial lesions or cutaneous lesions due to actinic keratosis, comprising, based on the total weight of the composition: - 10.0 weight per...
|
|
WO/2018/109275A1 |
The present application relates to a medical hydrogel comprising nanofibrillar cellulose, wherein the hydrogel has a viscosity in the range of 2500–9000 Pa·s and a water retention value in the range of 30–100 g/g. The present applic...
|
|
WO/2018/108256A1 |
The invention relates to a composition for cutaneous lesion dressing of cutaneous leishmanial lesions, comprising, based on the total weight of the composition: - 10.0 weight percent to 35 weight percent of a one or more diols, selected ...
|
|
WO/2018/109281A1 |
The present disclosure relates to method for drying hydrogel comprising nanofibrillar cellulose, the method comprising providing a hydrogel comprising nanofibrillar cellulose, providing polyethylene glycol, providing trehalose, mixing th...
|
|
WO/2018/109282A1 |
The present disclosure relates to method for drying cell-free tissue extract in a hydrogel comprising nanofibrillar cellulose, the method comprising providing a hydrogel comprising nanofibrillar cellulose, providing cell-free tissue extr...
|
|
WO/2018/104937A1 |
The present invention relates to antimicrobial formulations. More particularly, the invention relates to monovalent copper-containing and/or monovalent copper-generating products for healing wounds and burns, and particularly for chronic...
|
|
WO/2018/101720A1 |
The present invention relates to a medical device for curing a liquid bandage and a method for curing a liquid bandage using same. According to an embodiment of the present invention, the medical device for curing a liquid bandage includ...
|
|
WO/2018/097425A1 |
The present invention relates to a method for manufacturing a porous hydrogel sheet, and a porous hydrogel sheet manufactured by the manufacturing method, the method comprising the steps of: (1) preparing a hydrogel sheet composition sol...
|
|
WO/2018/090913A1 |
A degradable and absorbable hemostatic fiber material, a preparation method therefor, and a hemostatic fiber article thereof. The carboxylation degree of the hemostatic fiber material is 10-25%, and the polymerization degree of the hemos...
|
|
WO/2018/091890A1 |
Compositions for generating antimicrobial activity are described. The compositions comprise: a first phase; a second phase; an enzyme that is able to convert a substrate to release hydrogen peroxide;and a substance that includes a substr...
|
|
WO/2018/087779A1 |
The present subject matter describes a transdermal spray device and a transdermal delivery system maintained by the device. The device comprises means (101, 102, 103) for storing and dispensing of a transdermal delivery system, and at le...
|
|
WO/2018/080352A1 |
The present invention relates to the field of pharmaceutics and medicine, in particular, to a method for producing a suspended form of ground decellularized extracellular matrix with size-controlled structural components, the suspended f...
|
|
WO/2018/078340A1 |
The invention provides liquid formulations comprising dissolved oxygen (e.g. 10 mg/L up to 100 mg/L dissolved oxygen), and a substance which is capable of forming a gel upon contact with a body surface or body tissues, wherein said gel i...
|
|
WO/2018/080221A1 |
The present invention relates to a biopolymer-based hydrogel as a functional biomaterial using crosslinking with a photopolymerization initiator, and a method for producing the same. The present invention is biocompatible and elastic, an...
|
|
WO/2018/075018A1 |
The inventive subject matter provides kits, compositions and methods for treating or covering skin using a polymerizable formulation. The polymerizable formulation can include a first component including a siloxane polymer and a catalyst...
|
|
WO/2018/073837A1 |
The present invention relates to a topical dressing composition for the treatment of damaged skin tissue in a subject, wherein said topical dressing comprises mesenchymal stem cells embedded in a topical matrix. Particularly the inventio...
|
|
WO/2018/071278A1 |
Film-forming gel compositions, useful in creating conformable and flexible gel bandages, can be formulate from a film-forming polymer, an amine-rich adhesion promoter, and a volatile solvent. The gel compositions form relatively thick fi...
|
